NASDAQ: THEO
BOA Acquisition Corp. IICIK 0002080216 · SIC 6770 · Blank Checks
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (IREN 10-K) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade THEO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 26, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statements of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Six months ended June 30, 2026 |
|---|---|---|
| Formation, general and administrative expenses | 20,767 | 51,370 |
| NET LOSS | (20,767) | (51,370) |
| Basic and diluted weighted average shares outstanding, Class B ordinary shares (1) | 5,357,143 | 5,357,143 |
| Basic and diluted net loss per Class B ordinary share | (0.00) | (0.01) |
Consolidated Balance Sheets (Unaudited)
| Description | Jun 30, 2026 |
|---|---|
| Current assets: | |
| Cash and equivalents | — |
| TOTAL ASSETS | 1,173,705 |
| Current liabilities: | |
| Accounts payable | 98,099 |
| Other current liabilities | 1,132,729 |
| Total current liabilities | 1,230,828 |
| Long-term debt | 72,218 |
| Total liabilities | 1,303,046 |
| Shareholders' equity: | |
| Capital in excess of stated value | 24,384 |
| Retained earnings (deficit) | (154,341) |
| Total shareholders' equity | (129,341) |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 1,173,705 |
Condensed Statement of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 |
|---|---|
| Net loss | (51,370) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Changes in operating assets and liabilities: | |
| Accounts payable and accrued expenses | 20,213 |
| Net cash used in operating activities | (31,157) |
| CASH FLOW FROM FINANCING ACTIVITIES | |
| Operating expenses paid by Sponsor | 31,157 |
| Net cash provided by financing activities | 31,157 |
| NET CHANGE IN CASH | — |
| CASH, BEGINNING OF PERIOD | — |
| CASH, END OF PERIOD | — |
| SUPPLEMENTAL DISCLOSURES OF NONCASH ACTIVITIES | |
| Deferred offering costs included in accrued offering costs | 320,839 |
Amounts in USD as reported; EPS as reported. Statements found on the EDGAR/iXBRL face print as filed; the rest are presentation-friendly mappings of filer XBRL tags. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗